Anzeige
Mehr »
Samstag, 09.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QR0E | ISIN: US2075231017 | Ticker-Symbol:
NASDAQ
08.08.25 | 21:58
2,030 US-Dollar
-2,87 % -0,060
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CONNECT BIOPHARMA HOLDINGS LTD ADR Chart 1 Jahr
5-Tage-Chart
CONNECT BIOPHARMA HOLDINGS LTD ADR 5-Tage-Chart

Aktuelle News zur CONNECT BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.07.Connect Biopharma stock rating reiterated as Outperform by Northland5
22.07.Connect Biopharma erweitert Verwaltungsrat um Branchenveteran Jim Schoeneck4
22.07.Connect Biopharma erweitert Verwaltungsrat um Branchenveteran James A. Schoeneck1
22.07.Connect Biopharma Holdings Limited: Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors1
21.07.Connect Biopharma stock rises after announcing plan to terminate ADR program3
21.07.Connect Biopharma plant Direktlisting an der NASDAQ - Aktie steigt3
CONNECT BIOPHARMA Aktie jetzt für 0€ handeln
21.07.Connect Biopharma Holdings Limited: Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq213SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming...
► Artikel lesen
17.07.Connect Biopharma Regains Nasdaq Compliance On Minimum Bid Price358BEIJING (dpa-AFX) - Connect Biopharma Holdings Limited (CNTB), a clinical-stage biopharmaceutical company focused on inflammatory disease treatments, announced that it has regained compliance...
► Artikel lesen
17.07.Connect Biopharma regains Nasdaq compliance with $1 minimum bid price3
17.07.Connect Biopharma Holdings Limited: Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement151SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming...
► Artikel lesen
17.07.Connect Biopharma Holdings Ltd - 8-K, Current Report1
09.07.Connect Biopharma's partner submits new drug application in China2
09.07.Connect Biopharma: Partner reicht Zulassungsantrag für Rademikibart in China ein3
09.07.Connect Biopharma Holdings Limited: Connect Biopharma's Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China1
09.07.Connect Biopharma Holdings Ltd - 8-K, Current Report1
13.06.Connect Biopharma reports positive data for asthma treatment2
13.06.Connect Biopharma meldet positive Daten für Asthma-Behandlung3
13.06.Connect Biopharma Holdings Limited: Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress3
10.06.Connect Biopharma files $300M mixed securities shelf2
10.06.Connect Biopharma Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans1
Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1